Literature DB >> 9352248

Both plasma and renal endothelin-1 participate in the acute cardiovascular response to exercise.

G G Neri Serneri1, I Cecioni, A Migliorini, S Vanni, G Galanti, P A Modesti.   

Abstract

Plasma endothelin (ET-1) and renal endothelin are two distinct functional systems involved in maintaining blood volume. To investigate whether plasma and renal ET-1 participate in the cardiovascular response to exercise-induced hypovolaemia, we studied changes in plasma and urinary ET-1 in healthy non-professional athletes after 2 h of jogging performed both without and with drinking isotonic fluids. After the run, which caused a 13% plasma volume (PV) reduction, plasma and renal ET-1 (+117% and +118%) increased significantly (all P < 0.01). Fluid loss restitution during the run significantly attenuated either the PV contraction (-1.2%) and plasma and renal ET-1 increase (+2 and +3%). At multiple regression analysis changes in AVP plasma concentration, and not in PRA or PV per se, were significantly related to ET-1 changes both in plasma and urine. The present findings indicate that both plasma and renal ET-1 participate in the cardiovascular response to hypovolaemia induced by long-lasting, dynamic exercise.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352248     DOI: 10.1046/j.1365-2362.1997.1870736.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  Impairment of cardiopulmonary receptor sensitivity in the early phase of heart failure.

Authors:  P A Modesti; G Polidori; I Bertolozzi; S Vanni; I Cecioni
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

2.  The EDN1 Missense Variant rs5370G &gt; T Regulates Adaptation and Maladaptation under Hypobaric Hypoxia.

Authors:  Tsering Palmo; Bilal Ahmed Abbasi; Neha Chanana; Kavita Sharma; Mohammed Faruq; Tashi Thinlas; Malik Z Abdin; Qadar Pasha
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.